Interesting read ... https://cardiex.com/assessing-cardiovascular-risk-in-the-face-of-covid-19/
"The gold standard for non-invasive central blood pressure and arterial stiffness measurement is ATCOR’s SphygmoCor® XCEL. ATCOR technology equips healthcare providers with vital insights into their patients’ vascular health—including but not limited to arterial stiffness, pulse wave reflections, and central aortic blood pressure. This information will be critical as we move forward in our understanding, prevention, and treatment of individuals with COVID-19."
IMO highlights the huge potential of CDX's product uptake when they roll out their range of new, 'telemedicine ready' cardiovascular monitoring devices, based on ATCOR's Sphygmocor technology.
GLTA Holders
- Forums
- ASX - By Stock
- CDX Research
CDX
cardiex limited
Add to My Watchlist
2.50%
!
3.9¢

Interesting read ......
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.9¢ |
Change
-0.001(2.50%) |
Mkt cap ! $17.49M |
Open | High | Low | Value | Volume |
3.9¢ | 4.0¢ | 3.8¢ | $20.01K | 521.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 75000 | 3.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.2¢ | 60000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 75000 | 0.038 |
5 | 677100 | 0.037 |
2 | 263210 | 0.036 |
4 | 515503 | 0.035 |
3 | 382970 | 0.034 |
Price($) | Vol. | No. |
---|---|---|
0.042 | 60000 | 1 |
0.045 | 82414 | 2 |
0.050 | 100000 | 1 |
0.052 | 180000 | 1 |
0.080 | 100799 | 1 |
Last trade - 15.40pm 27/06/2025 (20 minute delay) ? |
Featured News
CDX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online